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Abstract The promoter of the cholecystokinin (CCK) gene
possesses evolutionary conserved juxtaposed E-box and cAMP/
TPA responsive elements (CRE/TRE). We have examined the
functional interaction of these two sites. As previously noted, c-
Jun/c-Fos heterodimers greatly increase promoter activity
through association with the CRE/TRE. Mutation of the E-
box enhanced the activation by c-Jun/c-Fos, as well as
stimulation by forskolin and bFGF, that acts through the
CRE/TRE site. Moreover, c-Jun/c-Fos stimulation was inhibited
by co-expression of c-Myc and Max. The results indicate that
factors associating with the E-box exhibit a negative cooperative
effect on the activation via the CRE/TRE element. We propose
that this mechanism plays a significant role in CCK gene
transcription and other genes with juxtaposed E-box and CRE/
TRE.
z 1999 Federation of European Biochemical Societies.
Key words: Cholecystokinin (CCK) gene promoter;
Juxtaposed E-box and cAMP/TPA responsive elements
(CRE/TRE); Negative cooperativity
1. Introduction
Cholecystokinin (CCK) is a peptide hormone and neuro-
transmitter primarily expressed in endocrine gut cells and neu-
rons in the brain and gut (for review see [1]). Previous studies
on the proximal promoter region of the CCK gene have iden-
ti¢ed a number of known transcriptional regulatory motifs
including a TATA box, an Sp1 binding site, a basic region/
helix-loop-helix/leucine zipper (bHLH-ZIP) E-box, and a
combined cAMP-response and TPA-response element (CRE/
TRE) [2,3]. The spacing and positioning of these elements are
highly conserved in evolution from elasmobranch to man
(Fig. 1). Only the shark promoter lack an E-box [4,5]. The
conservation suggests that the motifs play a crucial role in the
spatial and temporal control of CCK gene expression.
The E-box 5P-CACGTG-3P motif is recognized by members
of the bHLH-ZIP group of transcription factors. This family
includes among other factors the Myc oncogenes (for review,
see [6]), Max [7,8], as well as the upstream stimulatory factors
(USF) 1 and 2 [9,10]. Protein-protein interaction within the
bHLH-ZIP region results in the formation of homo- and het-
erodimers that bind the E-box motif, which can lead to either
the activation or repression of gene transcription [6]. The
CRE/TRE motif consists of a core consensus sequence of
5P-GCGTCA-3P that is identical to the proenkephalin CRE-
2 element [11] and the 3296 element of the human c-fos gene
[12]. Like the E-box, CRE/TRE elements are recognized by
numerous transcription factors including CREB [13], ATF
[14], c-Jun [15] and c-Fos [16]. Co-transfection experiments
in SK-N-MC cells with a CCK promoter reporter construct
have shown that CREB, c-Jun and c-Fos were all able to
stimulate promoter activity through the CRE/TRE motif,
with maximal stimulation when c-Jun and c-Fos were ex-
pressed concurrently [3].
Numerous genes posses both an E-box and an CRE/TRE in
their proximal promoter region, including the murine AH
receptor gene [17], the rat preprotachykinin-A gene [18], the
rat tyrosine hydroxylase gene [19], the human ATF3 gene [20],
the promoter region of the human preproenkephalin gene [11]
and the human Alzheimer amyloid L-protein precursor gene
[21]. Previously we raised the possibility that cross-talk be-
tween transcription factors binding the juxtaposed E-box
and CRE/TRE motifs of the CCK gene promoter may play
a crucial role in CCK gene transcription. Here we describe co-
transfection studies involving c-Myc, Max, c-Jun, and c-Fos
and provide evidence for negative cooperativity between the
two sites upon binding of transcription factors.
2. Materials and methods
2.1. Expression and reporter plasmids
pCMV-Myc, pCMV-USF1 and pCMV-Max, encoding human c-
Myc, human USF1 and murine Max (also known as Myn) respec-
tively, in the pcDNA I vector (Invitrogen) have previously been de-
scribed by Li et al. [22]. The pSV-c-Fos [23] and pRSV-c-Jun [24]
expression constructs were obtained from Morten Johnsen (University
of Copenhagen, Denmark).
Three previously described reporter constructs encompassing the
proximal 100 bp of the human CCK promoter linked to the coding
region of the bacterial chloramphenicol acetyl transferase (CAT) gene
were used to monitor transcriptional activation/repression. pCCK-100
contains the wild-type CCK promoter in the pCAT-basic (Promega),
whereas pCCK-100-vE-box and pCCK-100-vCRE/TRE possess mu-
tated E-box (5P-CACGTG-3P to 5P-TACATA-3P) and CRE/TRE mo-
tifs respectively (5P-CTGCA-3P to 5P-CTGAA-3P).
2.2. Cell culture and transfections
All experiments were performed using the human neuroblastoma
cell line SK-N-MC (obtained from the Department of Pathology,
University of Uppsala, Sweden) which expresses CCK at a high level
[25]. Cells were cultured in 40.5% Dulbecco’s minimal Eagle’s me-
dium, 40.5% Ham’s F-12 medium (GIBCO BRL) supplemented
with 15% fetal calf serum (GIBCO BRL), 1% penicillin, 1% strepto-
mycin, 1% glutamine and 1% non-essential amino acids. A total of
25 Wg of DNA, including 5 Wg of one of the three reporter constructs
and 2 Wg of pCMVL-gal, were mixed with 2.5U106 exponentially
growing cells using a calcium phosphate precipitation procedure
[26]. When required, pBluescript (Stratagene) was to standardize the
quantity of DNA used in the transfections. Brie£y, the DNA was
suspended in 1 ml 0.125 M CaCl2, 25 mM N,N-bis(2-hydroxyethyl)-
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2-aminoethane-sulfonic acid (pH 6.95), 140 mM NaCl and 0.75 mM
Na2HPO4 and left at room temperature for 20 min. This solution was
then added to the cells and incubated overnight at 35‡C in 3% CO2
atmosphere. The following morning, fresh media were added and the
cells incubated for 24 h at 37‡C in 10% CO2 atmosphere.
Stimulations were performed in fully complemented media and in-
cluded 25 ng/ml basic ¢broblast growth factor (bFGF) (Promega)
and/or 10 WM forskolin (Sigma) added 6 h before harvesting of the
cells.
2.3. CAT and L-galactosidase assays
Cell extracts were prepared from transfected SK-N-MC cells as
outlined by Gorman et al. [27]. CAT activity was determined utilizing
the CAT Enzyme Assay System with Reporter Lysis Bu¡er (Promega,
USA) by following the procedure outlined by the supplier. L-galacto-
sidase production was measured to normalize for transfection e⁄-
ciency as previously described [28].
3. Results
3.1. E¡ect of bHLH-ZIP factors and CREB on CCK
transcription
Independent expression plasmids encoding three members
of the bHLH-Zip transcription factor family, c-jun and c-fos
were transfected into SK-N-MC cells in conjunction with
pCCK-100 to analyse their in£uence on reporter gene expres-
sion (Table 1). At the highest transfection rates USF1 (5 Wg)
resulted in a 3.6-fold stimulation of CAT activity above basal.
In comparison c-Myc produced a 1.8-fold increase in pro-
moter activity, whereas Max had no e¡ect on promoter activ-
ity (data not shown). Co-expression of c-Myc and Max en-
hanced promoter activity 2.5-fold above basal. In accordance
with the known binding site of bHLH-Zip transcription fac-
tors, mutation of the E-box within the proximal promoter
region resulted in a reduction of USF1 mediated activation,
as well as co-expressed c-Myc and Max, induced reporter gene
expression (Table 1). Finally c-Jun and c-Fos increased tran-
scription more than 40-fold via the CRE/TRE.
3.2. Mutation of E-box element stimulates activation via the
CRE/TRE element
The in£uence of factors binding the E-box and CRE/TRE
elements on activation via the juxtaposed element was exam-
ined ¢rstly by mutation of the two elements in the CCK-100
construct (Table 1). Inactivation of the E-box resulted in a
2^3-fold enhancement of activation by c-Jun/c-Fos, whereas
activation by USF1 was increased 2-fold by mutation of the
CRE/TRE element. Promoter activity in the presence of
c-Myc and Max was unchanged after mutation of the CRE/
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Fig. 1. Comparison of the proximal promoter regions of the human [36], rat [2], bullfrog [4] and dog¢sh [5] CCK genes. The consensus se-
quences for E-box, CRE/TRE, Sp1 and TATA box elements are underlined and labelled appropriately.
Table 1
E¡ect of mutating the E-box and CRE/TRE binding sites on CCK gene promoter activity
Transcription factor CCK-100 wild-type (fold induction) CCK-100-vE-box (fold induction) CCK-100-vCRE/TRE (fold induction)
c-Fos/c-Jun (2.5/2.5 Wg) 42.7 (4.6) 90.0 (8.6) 5.2 (2.0)
USF1 (5 Wg) 3.6 (0.4) 2.1 (0.1) 6.8 (0.4)
Myc/Max (3.75/1.25 Wg) 2.5 (0.2) 1.7 (0.2) 2.1 (0.7)
The reporter constructs, pCCK-100 (wild-type), pCCK-100-vE-box and pCCK-100-vCRE/TRE were each co-transfected with either pRSV-c-Jun/
pSV-c-Fos, pCMV-USF1 or pCMV-Myc/pCMV-Max. All data have been normalized to the level of L-galactosidase, and are presented as fold
stimulation above CAT activity when reporter construct was transfected alone. Results are expressed as the mean of four experiments þ S.E.M.
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TRE site and slightly reduced by mutation of the E-box (Ta-
ble 1).
To examine the e¡ect of the E-box motif on the CRE/TRE
element under physiological conditions, SK-N-MC cells were
transfected with wild-type pCCK-100, pCCK-100-vCRE/
TRE, pCCK-100-vE-box reporter constructs and exposed to
basic ¢broblast growth factor (bFGF) or forskolin, that stim-
ulates promoter activity via the CRE/TRE [29] (Fig. 2). CAT
activity was stimulated 2-fold by bFGF, 10-fold by forskolin
and 20-fold by bFGF and forskolin together. Following mu-
tation of the CRE/TRE element, activation was almost com-
pletely inhibited, demonstrating that activation is mediated
via the CRE/TRE element. However, as observed above, mu-
tation of the E-box motif enhanced the stimulatory e¡ect of
each of the stimulants and their synergistic activation 2^3-
fold.
3.3. Co-expression of c-Myc and Max inhibits activation by
c-Jun/c-Fos
Since mutation of the E-box motif in the proximal pro-
moter reporter construct resulted in enhanced promoter activ-
ity, we also examined the e¡ect of expressing c-Myc and Max
with c-Jun and c-Fos. The presence of c-Myc and Max greatly
reduced the ability of c-Jun and c-Fos to activate reporter
gene expression (Fig. 3). The repression was dependent on
DNA binding, since c-Myc and Max expression no longer
a¡ected the ability of co-expressed c-Jun and c-Fos to stim-
ulate CCK gene promoter activity when the experiment was
repeated utilizing the pCCK-100-vE-box plasmid.
4. Discussion
The present study has examined the function of transcrip-
tion factors binding to the evolutionary conserved and juxta-
posed E-box and CRE/TRE elements in the human CCK gene
promoter.
The mammalian CCK gene and the related gastrin gene are
believed to have originated via gene duplication events which
occurred before, or perhaps during, the appearance of carti-
laginous ¢sh [5]. Both the gastrin and CCK genes in dog¢sh
possess putative CRE/TRE binding sites whereas the gastrin
genes from bullfrogs, mice and humans lack this motif [4,5].
Therefore it could be argued that the appearance of an E-box
element in CCK genes and the loss of a CRE/TRE site in
gastrin genes from higher vertebrates have played a role in
the evolution of cell speci¢c expression of these genes.
We examined the in£uence of factors binding to the E-box
and CRE/TRE elements on the activation of the juxtaposed
element in three situations. First, the activity of c-Jun/c-Fos
and bHLH-ZIP factors was shown to be increased when the
juxtaposed elements were mutated. Second, the e¡ect of
bFGF and forskolin, that activate the promoter via the
CRE/TRE in a CREB dependent manner [29] was demon-
strated to be enhanced following mutation of the E-box and
¢nally co-expression of Myc and Max was shown to com-
pletely block activation by c-Jun/c-Fos. Taken together the
results show that simultaneous binding of bHLH-ZIP and
members of the CREB and AP-1 family of transcription fac-
tors exhibit a negative cooperative e¡ect on the activation of
the juxtaposed element. Consequently the amount of tran-
scription factors such as c-Myc/Max and c-Jun/c-Fos may
dictate in vivo CCK gene transcription.
How the negative cooperative e¡ect is accomplished is un-
clear. The spacing between the E-box and CRE/TRE elements
is conserved between the bullfrog and mammalian CCK pro-
moters, with the core of the elements being separated by 12 bp
or V3.4 nm in ordinary B-DNA. Crystal data have shown
that the bHLH-DNA binding domain binds to the major
groove of the symmetrical CACGTG sequence in B-DNA
[30,31]. The structure of the c-Jun/c-Fos binding complex is
similar in the sense that the N-terminal region of the hetero-
dimer also makes base speci¢c contacts with the DNA in the
major groove [32]. Although the e¡ects of Myc and Max were
dependent on binding of the heterodimer to DNA, suggesting
that the negative cooperativity is the result of steric hindrance,
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Fig. 2. The in£uence of mutating the E-box and CRE/TRE binding
sites of the CCK promoter on bFGF and forskolin stimulated CAT
activity. SK-N-MC cells transfected with either the pCCK-100,
pCCK-100-vE-box or pCCK-100-vCRE/TRE reporter constructs
were treated with bFGF (25 ng/ml), forskolin (10 WM) or both
agents 6 h before harvesting of the cells. All data have been normal-
ized to the expression level of L-galactosidase, and are presented as
fold stimulation above CAT activity when reporter construct was
transfected alone. Results are expressed as the mean of four experi-
ments þ S.E.M.
Fig. 3. Mutation of the E-box motif within the human CCK gene
promoter abrogates the ability of c-Myc/Max to reduce c-Jun/c-Fos
activation of CCK-CAT reporter gene expression. pCMV-Myc (3.75
Wg) and pCMV-Max (1.25 Wg) where transfected without and with
2.5 Wg of both the pRSV-c-Jun and pSV-c-Fos expression constructs
in the presence of the pCCK-100 or pCCK-100-vE-box reporter
constructs. All data have been normalized to the expression level of
L-galactosidase, and are presented as fold stimulation above CAT
activity when reporter construct was transfected alone. Results are
expressed as the mean of four experiments þ S.E.M.
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this is not directly supported by the crystallographic data or
previous footprinting experiments [3]. Another possibility is
therefore that the factors compete for putative co-factors or
the general transcription complex e.g. the multiprotein com-
plex TFII-D that associate with both USF [9], Myc [33] and
members of the leucine zipper family [34,35].
The proximal promoter regions of many other genes possess
both E-box and CRE/TRE binding sites. However we have
not found studies similar to the present where the interplay of
factors binding these motifs has been analyzed. Consequently
our observation that proteins binding the E-box have a neg-
ative in£uence on promoter activation through the CRE/TRE
element of the human CCK gene may have implications for
many other genes which possess these regulatory elements in
close proximity, such as the human amyloid L-protein precur-
sor gene promoter [21], the murine AH receptor gene pro-
moter [17], the rat tyrosine hydroxylase gene promoter [19]
and the human activating transcription factor 3 gene pro-
moter [20].
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